Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674946 | SCV000800362 | likely pathogenic | Metachromatic leukodystrophy | 2018-06-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000674946 | SCV001384324 | pathogenic | Metachromatic leukodystrophy | 2023-12-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg293*) in the ARSA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSA are known to be pathogenic (PMID: 8962139, 10477432). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with metachromatic leukodystrophy (PMID: 26553228, 31069529). ClinVar contains an entry for this variant (Variation ID: 558645). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000674946 | SCV001526059 | pathogenic | Metachromatic leukodystrophy | 2018-12-05 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. The c.877C>T (p.R293*) variant has been previously reported as disease-causing [PMID 26553228] |